Home/Filings/4/0001104659-22-030184
4//SEC Filing

Harshbarger Benjamin 4

Accession 0001104659-22-030184

CIK 0001454789other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 7:21 PM ET

Size

5.5 KB

Accession

0001104659-22-030184

Insider Transaction Report

Form 4
Period: 2022-03-01
Harshbarger Benjamin
Chief Legal Officer
Transactions
  • Award

    Stock Option (right to buy)

    2022-03-01+55,00055,000 total
    Exercise: $6.51Common Stock (55,000 underlying)
Footnotes (1)
  • [F1]This option was granted on March 1, 2022 and is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of February 17, 2022 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.

Issuer

Astria Therapeutics, Inc.

CIK 0001454789

Entity typeother

Related Parties

1
  • filerCIK 0001653133

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 7:21 PM ET
Size
5.5 KB